Colorado-based kidney care company DaVita has agreed to pay about $34.5 million to resolve allegations that it violated the False Claims Act by paying kickbacks to induce referrals to DaVita Rx, a former subsidiary that provided pharmacy services for dialysis patients, according to the U.S. Department of Justice.
It was also alleged that DaVita paid kickbacks to nephrologists and vascular access physicians to induce the referral of patients to DaVita’s dialysis centers.
